iih and glp 1 Metabolic pathogenesis treatment in IIH. is most prevalent in GLP-1 Agonists May Help Reduce

GLP-1RAs do not cause broad immunosuppression and are associated with reduced risk of serious infections

Each program decides whether it includes labs, partially includes them, or charges for them separately, and repeated lab testing can increase total cost over one month, three months, and beyond

Side Effects: Common Side Effects 1

FARXIGA (dapagliflozin) tablets, for oral use

"Not medically necessary" or "step therapy required" = PA denial (you can appeal) "Excluded benefit" or "not covered" = plan exclusion (different strategy needed) WHAT'S COMING BCBS Coverage Changes for 2026 Coverage Outlook for 2026 Exclusions remain common across many BCBS plans for Zepbound in 2026 even for patients who previously had coverage

These medications are not recommended during pregnancy